Grade: Pharmaceutical Grade

Factory Location: Nanjing City,China

Main Sales Markets: Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Orforglipron is a GLP-1 receptor agonist that lowers blood glucose levels by stimulating insulin secretion and suppressing glucagon secretion, thereby treating type 2 diabetes and obesity/overweight. Orforglipron also delays gastric emptying, which positively regulates appetite and food intake, ultimately leading to weight loss.